Acorda Therapeutics Inc (ACORQ)

Acorda Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	0	19	19	27	33	98
Market Cap Growth	0.45%	0.45%	-30.30%	-19.11%	-66.22%	-86.78%
Enterprise Value	161	179	147	152	190	179
PE Ratio	-	-0.07	-0.28	-0.26	-0.33	-0.36
PS Ratio	0.00	0.16	0.16	0.21	0.22	0.51
PB Ratio	-0.12	-0.12	0.20	0.18	0.14	0.32
P/FCF Ratio	-1.32	-1.32	-0.89	-0.64	-0.51	-0.45
P/OCF Ratio	-1.34	-1.34	-0.89	-0.65	-0.54	-0.76
EV/Sales Ratio	1.37	1.52	1.24	1.18	1.24	0.93
EV/EBITDA Ratio	-0.77	-0.77	5.29	-3.38	-5.31	-0.82
EV/EBIT Ratio	-0.68	-0.68	-29.11	-1.93	-2.47	-0.71
EV/FCF Ratio	-12.56	-12.56	-6.98	-3.67	-2.91	-0.82
Debt / Equity Ratio	-1.21	-1.21	1.85	1.26	1.09	0.80
Debt / EBITDA Ratio	-0.82	-0.82	6.23	-4.24	-7.26	-1.15
Debt / FCF Ratio	-13.40	-13.40	-8.21	-4.60	-3.97	-1.14
Quick Ratio	0.21	0.21	1.54	1.52	0.90	2.21
Current Ratio	0.33	0.33	2.16	1.89	1.61	2.33
Asset Turnover	0.39	0.39	0.29	0.26	0.22	0.19
Interest Coverage	-8.39	-8.39	-0.17	-2.63	-2.52	-11.54
Return on Equity (ROE)	-2206.90%	-2206.90%	-68.50%	-58.40%	-34.70%	-64.10%
Return on Assets (ROA)	-83.30%	-83.30%	-16.30%	-20.80%	-14.10%	-26.60%
Return on Capital (ROIC)	-833.57%	-833.57%	-15.77%	-22.60%	-29.91%	-71.12%
Earnings Yield	-84827.56%	-1349.04%	-353.25%	-388.27%	-300.90%	-278.59%
FCF Yield	-4779.92%	-76.02%	-112.86%	-155.05%	-197.58%	-223.10%
Buyback Yield / Dilution	-22.85%	-22.85%	-90.38%	-31.38%	-1.98%	-0.47%
Total Shareholder Return	-22.85%	-22.85%	-90.38%	-31.38%	-1.98%	-0.47%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).